正因为如此，要通过化疗治疗小细胞癌症。
Because of this, small cell lung cancer is treated with chemotherapy.
对于小细胞肺癌而言，通常不选择手术疗法。
小细胞肺癌术后化疗后预防性脑照射是否必要?。
Is prophylactic brain irradiation necessary after surgery and chemotherapy for small cell lung cancer?
放疗加gp方案化疗治疗中晚期非小细胞肺癌疗效观察。
Clinical effect of radiotherapy combined with GP regimen chemotherapy in advanced non - small cell lung cancer.
非小细胞肺癌病人的表皮生长因子受体基因突变的临床病理意义。
Clinicopathologic Significance of the Mutations of the Epidermal Growth Factor Receptor Gene in Patients with Non-Small Cell Lung Cancer.
背景与目的化疗在晚期非小细胞肺癌的治疗中具有极为重要的作用。
Background and objective Chemotherapy is very important in the treatment of advanced non-small cell lung cancer.
目的：分析食管小细胞癌的临床特点及疗效，探讨合适的治疗模式。
Objective: Analyse clinical features of neuroendocrine carcinoma of esophagus (NCE) and outcome and investigate treatment modality with literatures.
持续静脉输注国产异长春花碱加顺铂治疗晚期非小细胞肺癌临床观察。
Cisplatin and continuous infusion homemade vinorelbine combination chemotherapy for advanced Non-small cell lung cancer.
一种是小细胞肺癌，这种肺癌更具侵袭性，在早期就能扩散到其他器官。
Small-cell lung cancer is the more aggressive of the two, meaning it can spread quickly to other parts of the body early in the disease.
目的：为了测定美国非小细胞肺癌患者的流行病学、病理学和治疗模式。
PURPOSE: To determine the epidemiology, pathology and patterns of care for patients with non-small cell lung cancer (NSCLC) in the United States.
同时，TNM系统也可用于小细胞癌（SCLC），但并非以此作为治疗指南。
The TNM system may be applied to small-cell lung cancer (SCLC), but management decisions are not as closely guided by it.
另外一种非小细胞癌，生长更慢些，也更为常见，90%的肺癌都是这种类型。
Non-small-cell lung cancer grows more slowly and is more common, accounting for almost 90% of all lung cancers.
小细胞癌常无明显的大核仁（而恶性黑色素瘤常有），偶尔伴有核内假包涵体。
Small cell carcinomas usually do not show large prominent nucleoli, whereas melanomas often do, accompanied by occasional intranuclear pseudoinclusions.
这项研究的目的是评估在小细胞肺癌患者中KIT表达的普遍性和它的预后价值。
The purpose of this study was to evaluate the prevalence of KIT expression in patients with SCLC and its prognostic value.
小细胞癌分为2期：局限性，肺癌局限一个肺中，可能邻近的淋巴结会有癌细胞；
Small-cell lung cancer is divided into two stages: "Limited" means the cancer is confined to one lung and maybe nearby lymph nodes.
塞克尔教授说：“我研究小细胞肺癌多年，发现能够消除大块肿瘤并使之消失是件美妙的事。”
Prof Seckl said: "I have been working on small cell lung cancer for many years and to find something that can take a measurable piece of tumour and make it go away is wonderful.
中国的非小细胞肺癌病人中吉非替尼敏感的表皮生长因子受体酪氨酸激酶区域的突变。
Gefitinib-sensitive mutations of the epidermal growth factor receptor tyrosine kinase domain in chinese patients with non-small cell lung cancer.
肿瘤病学家在对可疑或确诊的非小细胞肺癌患者进行分期时要面临多方面因素的考量。
Medical oncologists are faced with multiple factors to consider when staging a patient with suspected or confirmed non-small cell lung cancer (NSCLC).
肺癌的TNM系统最初用于非小细胞癌(NSCLC)，这种癌大约占所有肺癌的75%。
The TNM lung cancer staging system is primarily utilized for non-small-cell lung cancer (NSCLC), which accounts for approximately 75% of lung cancer diagnoses.
对于小细胞肺癌的患者，手术通常并不是最好的选择，因为往往在诊断的时候就已经扩散了。
Surgery is usually not an option for patients with small-cell lung cancer because it typically has already spread at the time of diagnosis.
有两种主要类型：最常见的是“非小细胞肺癌”；另一种是扩展非常迅速的“小细胞肺癌”。
There are two major types: non-small cell lung cancer, which is the most common, and small cell lung cancer, which spreads more quickly.
目的观察了解吉西他滨单药治疗老年晚期非小细胞肺癌(NSCLC)的临床疗效和毒性反应。
Objective: to evaluate the clinical effect and toxicity of gemcitabine monotherapy in the treatment of elder advanced non-small cell lung cancer (NSCLC).
1/5的癌症患者带有一种特别的有毒病株，称为小细胞肺癌，这种肺癌五年内杀死了近3%的确诊患者。
One in five lung cancer sufferers have a particularly virulent strain called small cell lung cancer which kills all but three per cent of sufferers within five years of diagnoses.
目的探讨非小细胞肺癌组织中COX 2的表达情况及其与患者临床病理生理特征和预后的关系。
Objective to investigate the expression of COX-2 and its relation to clinical pathophysiological features and prognosis in non-small cell lung cancer (NSCLC).
目的探讨非小细胞肺癌组织中COX 2的表达情况及其与患者临床病理生理特征和预后的关系。
Objective to investigate the expression of COX-2 and its relation to clinical pathophysiological features and prognosis in non-small cell lung cancer (NSCLC).
应用推荐